In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Integra LifeSciences Holdings Corporation

http://www.integralife.com/

Latest From Integra LifeSciences Holdings Corporation

Korea Q3 Roundup: Mixed Results Amid Focus On Obesity, New Drugs

As Korean firms report quarterly earnings, Hanmi is stepping up the development of obesity drugs, Daewoong unveils plans to boost sales of in-house new drugs, GC Biopharma’s immunoglobulin undergoes the US approval process and Ildong has set up a new R&D-focused subsidiary.

South Korea Sales & Earnings

Deal Watch: Bayer Ties Up With Twist On Optimization Of Antibody Discovery

Plus deals involving Advanz/Dimerix, Boehringer Ingelheim/Zeiss Medical Technology, Roche/Ionis, Kriya/Everads and updates from the world of technology transfer.

Deal Watch Business Strategies

Finance Watch: UroGen Accesses Cash After Phase III Bladder Cancer Success

Public Company Edition: UroGen raised $120m in a private placement of ordinary shares. Also, Verrica entered into a debt financing for up to $125m upon approval of Ycanth for molluscum contagiosum and job cuts were announced by Homology, Mersana, Infinity and others.

Financing Restructuring

Finance Watch: Apogee, Sagimet Launch First Big US IPOs Of The Summer

Public Company Edition: Apogee grossed $300m and Sagimet raised $85m in the biggest initial public offerings in the US since Acelyrin’s $540m IPO in May. Also, Bausch entered into a $600m funding facility with KKR, Bicycle raised $200m in a FOPO and Caribou garnered $150m from an offering and Pfizer.

Financing Growth
See All

Company Information

  • Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Other Names / Subsidiaries
    • ACell, Inc.
    • Arkis BioSciences
    • Ascension Orthopedics
    • Confluent Surgical, Inc.
    • Derma Sciences, Inc.
    • IsoTis Orthobiologics, Inc.
    • Minnesota Scientific
    • Newdeal SA
    • Omni-Tract Surgical
    • Innovative Spinal Technologies Inc.
    • Rebound Therapeutics
    • Surgical Innovation Associates
    • TEI Biosciences Inc.
    • TEI Medical Inc.
    • Terragraphix, Inc.
    • TGX Medical
    • TGX Medical Systems, LLC
    • MCF I LP THX  Medical  System  LLC  Holdings, Inc.
UsernamePublicRestriction

Register